Last reviewed · How we verify
Gardasil® HPV vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Gardasil® HPV vaccine (Gardasil® HPV vaccine) — London School of Hygiene and Tropical Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Gardasil® HPV vaccine TARGET | Gardasil® HPV vaccine | London School of Hygiene and Tropical Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Gardasil® HPV vaccine CI watch — RSS
- Gardasil® HPV vaccine CI watch — Atom
- Gardasil® HPV vaccine CI watch — JSON
- Gardasil® HPV vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Gardasil® HPV vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/gardasil-hpv-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab